$4.67
0.316.64%
At close: Sep 18, 8:14 AM EDT
$4.98
0.316.64%
After Hours: Sep 18, 8:14 AM EDT
15 minutes delayed
Comments
Loading...
Molecular Partners (MOLN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMolecular Partners (NASDAQ:MOLN) Stock Quotes, Forecast and News Summary
Molecular Partners Stock (NASDAQ: MOLN) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 137.00 / 26.04K |
| Day Range | - - - |
| 52 Wk Range | 3.32 - 12.70 |
| Market Cap | $165.31M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 33 |
| Short Interest | 0.13% |
| Days to Cover | 6.76 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Molecular Partners AG
Sector
Health Care
Industry
Biotechnology
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in var...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Molecular Partners (MOLN) stock?
You can purchase shares of Molecular Partners (NASDAQ:MOLN) through any online brokerage.
Who are Molecular Partners (MOLN) competitors?
Other companies in Molecular Partners’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Inovio Pharmaceuticals (NASDAQ:INO).
What is the forecast, or price target, for Molecular Partners (MOLN) stock?
Molecular Partners has a consensus price target of $6.25.
What is the current price for Molecular Partners (MOLN)?
The stock price for Molecular Partners (NASDAQ: MOLN) is $4.98 last updated September 18, 2024 at 8:14 AM EDT.
Does Molecular Partners (MOLN) pay a dividend?
There are no upcoming dividends for Molecular Partners.
When is Molecular Partners (NASDAQ:MOLN) reporting earnings?
Molecular Partners’s H1 earnings are confirmed for Monday, August 26, 2024.
Is Molecular Partners (MOLN) going to split?
There is no upcoming split for Molecular Partners.
What sector and industry does Molecular Partners (MOLN) operate in?
Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.